FHL3 links cell growth and self-renewal by modulating SOX4 in glioma

[1]  G. Fuller,et al.  Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression , 2017, Oncogene.

[2]  Jing Wang,et al.  LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..

[3]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[4]  F. Wu,et al.  NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma , 2017, Oncogene.

[5]  Shawn M. Gillespie,et al.  Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.

[6]  E. Maher,et al.  Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. , 2017, Cell reports.

[7]  B. Devaux,et al.  A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma , 2016, Acta Neuropathologica.

[8]  J. Golfinos,et al.  Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor12 , 2016, Neoplasia.

[9]  Y. Iwadate,et al.  Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma , 2016, Journal of Neuro-Oncology.

[10]  D. Compton,et al.  Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells. , 2016, Cancer discovery.

[11]  Ling Li,et al.  SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis , 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  Jennifer S. Yu,et al.  Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation. , 2014, Cell reports.

[13]  R. Mao,et al.  SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis , 2014, BMC Neurology.

[14]  D. Pisano,et al.  Sox4 Links Tumor Suppression to Accelerated Aging in Mice by Modulating Stem Cell Activation , 2014, Cell reports.

[15]  Y. Shyr,et al.  PPM1A is a RelA phosphatase with tumor suppressor-like activity , 2014, Oncogene.

[16]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[17]  R. Boxtel,et al.  The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? , 2013, Oncogene.

[18]  Xiaozhong Peng,et al.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3. , 2013, The Journal of clinical investigation.

[19]  Jueheng Wu,et al.  Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. , 2013, Cancer research.

[20]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[21]  M. Barcellos-Hoff,et al.  Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. , 2012, Cancer research.

[22]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[23]  V. Lefebvre,et al.  The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation , 2012, Nature Immunology.

[24]  G. Semenza,et al.  Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1* , 2012, The Journal of Biological Chemistry.

[25]  Xin-Hua Feng,et al.  PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3 , 2011, EMBO reports.

[26]  K. Miyazono,et al.  Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein* , 2011, The Journal of Biological Chemistry.

[27]  R. McLendon,et al.  Acidic stress promotes a glioma stem cell phenotype , 2011, Cell Death and Differentiation.

[28]  H. Wang,et al.  SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. , 2010, Carcinogenesis.

[29]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[30]  L. Hood,et al.  Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma , 2010, PloS one.

[31]  K. Miyazono,et al.  Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. , 2009, Cell stem cell.

[32]  David García-Dorado,et al.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.

[33]  H. Zhang,et al.  Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. , 2009, The Journal of clinical investigation.

[34]  Susan S. Brown,et al.  FHL3 binds MyoD and negatively regulates myotube formation , 2007, Journal of Cell Science.

[35]  Alejandra Bruna,et al.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. , 2007, Cancer cell.

[36]  C. Moskaluk,et al.  Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells , 2006, Oncogene.

[37]  Xueyan Duan,et al.  PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling , 2006, Cell.

[38]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[39]  Pengbo Liu,et al.  Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. , 2006, Cancer research.

[40]  C. Ra,et al.  FHL3 negatively regulates human high-affinity IgE receptor beta-chain gene expression by acting as a transcriptional co-repressor of MZF-1. , 2005, The Biochemical journal.

[41]  J. Matthews,et al.  The LIM Protein FHL3 Binds Basic Krüppel-like Factor/Krüppel-like Factor 3 and Its Co-repressor C-terminal-binding Protein 2* , 2003, The Journal of Biological Chemistry.

[42]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[43]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[44]  Jill S. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.